Antioxidant treatment of patients with Friedreich ataxia: Four-year follow-up

Archives of Neurology

Volumn 62, Issue 4, 2005, Pages 621-626

  Hart, Paul E ^a   Lodi, Raffaele ^b,d   Rajagopalan, Bheeshma ^b   Bradley, Jane L ^a   Crilley, Jenifer G ^b   Turner, Christopher ^a   Blamire, Andrew M ^b   Manners, David ^b   Styles, Peter ^b   Schapira, Anthony H V ^a,c   Cooper, J Mark ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BIO E VITAMIN; BIO QUINON Q10; IDEBENONE; UBIDECARENONE;

ADOLESCENT; ADULT; ARTICLE; BIOENERGY; BODY POSTURE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; ENERGY; ENERGY YIELD; FRIEDREICH ATAXIA; GAIT; HEART MUSCLE; HUMAN; KINETICS; LONG TERM CARE; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RATING SCALE; SCHOOL CHILD; SIDE EFFECT; SKELETAL MUSCLE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIOXIDANTS; CHILD; DRUG THERAPY, COMBINATION; ENERGY METABOLISM; FOLLOW-UP STUDIES; FRIEDREICH ATAXIA; HEART; HUMANS; IRON-BINDING PROTEINS; MIDDLE AGED; MITOCHONDRIA; MUSCLE, SKELETAL; MYOCARDIUM; OXIDATIVE STRESS; PILOT PROJECTS; TREATMENT OUTCOME; UBIQUINONE; VITAMIN E;

EID: 20144389286     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.62.4.621     Document Type: Article

References (16)

1. Campuzano V, Montermini L, Lutz Y, et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet. 1997;6:1771-1780.
2. Duby G, Foury F, Ramazzotti A, Herrmann J, Lutz T. A non-essential function for yeast frataxin in iron-sulfur-cluster assembly. Hum Mol Genet. 2002;11:2635-2643.
3. Lodi R, Cooper JM, Bradley JL, et al. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci U S A. 1999;96:11492-11495.
4. 31P magnetic resonance spectroscopy study is abnormal. Cardiovasc Res. 2001;52:111-119.
5. Bradley JL, Homayoun S, Hart PE, Schapira AH, Cooper JM. Role of oxidative damage in Friedreich's ataxia. Neurochem Res. In press.
6. Lodi R, Rajagopalan B, Hart PE, et al. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Ann Neurol. 2001;49:590-596.
7. Trouillas P, Takayanagi T, Hallett M, et al. International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. J Neurol Sci. 1997;145:205-211.
8. Nierenberg DW, Lester DC. Determination of vitamins A and E in serum and plasma using a simplified clarification method and high-performance liquid chromatography. J Chromatogr. 1985;345:275-284.
9. 10, alpha-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. J Chromatogr. 1988;425:87-97.
10. 10 in the rat following its oral and intraperitoneal administration. Drug Metab Dispos. 1992;20:423-427.
11. 10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci U S A. 1998;95:8892-8897.
12. Puccio H, Simon D, Cossée M, et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet. 2001;27:181-186.
13. Hausse AO, Aggoun Y, Bonnet D, et al. Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia. Heart. 2002;87:346-349.
14. Buyse G, Mertens L, Di Salvo G, et al. Idebenone treatment in Friedreich's ataxia. Neurology. 2003;60:1679-1681.
15. Mariotti C, Solari A, Torta O, et al. Idebenone treatment in Friedreich's patients: one-year-long randomized placebo-controlled trial. Neurology. 2003;60:1676-1679.
16. Schols L, Vorgerd M, Schillings M, et al. Idebenone in patients with Friedreich ataxia. Neurosci Lett. 2001;306:169-172.